Cohort PLC Company Profile (LON:CHRT)

Analyst Ratings

Consensus Ratings for Cohort PLC (LON:CHRT) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 421.33

Analysts' Ratings History for Cohort PLC (LON:CHRT)
Show:
DateFirmActionRatingPrice TargetActions
7/8/2016Canaccord GenuityReiterated RatingBuyGBX 424View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2015Panmure GordonBoost Price TargetBuyGBX 300 -> GBX 420View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015InvestecBoost Price TargetBuyGBX 400 -> GBX 420View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Cohort PLC (LON:CHRT)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Cohort PLC (LON:CHRT)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cohort PLC (LON:CHRT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/28/2016GBX 4.101.36%8/25/20168/25/20169/21/2016Tweet This Announcement  Share This Announcement on StockTwits
12/14/2015GBX 1.900.47%2/4/20162/4/20163/2/2016Tweet This Announcement  Share This Announcement on StockTwits
6/25/2015GBX 3.401.19%8/27/20158/27/20159/30/2015Tweet This Announcement  Share This Announcement on StockTwits
12/15/2014GBX 1.600.67%2/5/20152/5/20153/4/2015Tweet This Announcement  Share This Announcement on StockTwits
6/26/2014GBX 2.801.37%8/27/20148/27/20149/24/2014Tweet This Announcement  Share This Announcement on StockTwits
12/16/2013GBX 1.400.72%2/5/20142/5/20143/5/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Cohort PLC (LON:CHRT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/15/2016Thomis,Andrew StephenInsiderBuy26GBX 390£101.40Tweet This Trade  Share This Trade on StockTwits
4/13/2016Walther,SimonInsiderBuy8,040GBX 372£29,908.80Tweet This Trade  Share This Trade on StockTwits
4/12/2016Thomis,Andrew StephenInsiderBuy2,350GBX 376£8,836Tweet This Trade  Share This Trade on StockTwits
4/11/2016Thomis,Andrew StephenInsiderSell218,541GBX 375£819,528.75Tweet This Trade  Share This Trade on StockTwits
2/9/2016Walmsley,Sir RobertInsiderBuy4,965GBX 332£16,483.80Tweet This Trade  Share This Trade on StockTwits
12/15/2015Perrin,Jeffrey LawrenceInsiderBuy4,000GBX 390£15,600Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cohort PLC (LON:CHRT)
DateHeadline
07/19/16 01:33 PMCohort Plc – Value Analysis (LONDON:CHRT) : July 19, 2016 -
07/13/16 03:40 AMCohort Plc breached its 50 day moving average in a Bullish Manner : CHRT-GB : July 13, 2016 -
07/12/16 08:23 AMCritical Outcome Initiates Third Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers - [at noodls] - Microsoft Word - 160712_Third Cohort Dosing.docx Press Release CRITICAL OUTCOME INITIATES THIRD COHORT IN PHASE 1 STUDY OF COTI‐2 IN GYNECOLOGIC CANCERS Independent Dose Escalation Committee recommends ...
06/29/16 08:15 PMIndustry Center - Aerospace/Defense - Major Diversified
06/28/16 06:59 AMShould you buy, sell or hold Ocado Group plc, Carpetright plc and Cohort plc on today’s results? -
06/28/16 06:07 AMFull Year 2016 Cohort PLC Earnings Release - Before Market Open -
06/20/16 02:49 AMSerodus announces that the first patient is randomized into the second cohort of the SER150 Ph2a study in Diabetic Nephropathy - [at noodls] - Oslo, 20. June 2016 Serodus (OSE: SER) today has randomized the first patient into the second and last cohort of the SER150 study in Diabetic Nephropathy. Patients are dosed with 30mg SER150 twice daily ...
06/01/16 02:43 AMSerodus announces initiation of second cohort in Ph2a study of SER150 in Diabetic Nephropathy - [at noodls] - Oslo, 01. June 2016 Serodus (OSE: SER) today received approval from the central German Ethics committee to initiate recruitment into the second cohort of the SER150 study in Diabetic Nephropathy. This ...
05/26/16 03:17 AMCohort Analysis: Its Full Potential - [at noodls] - The Cohort Analysis report in Google Analytics, has been out for a year now, so it's about time to see the full potential of this report! What is a cohort? A cohort, is a group of users that share a particular ...
05/23/16 03:45 AMCohort Plc breached its 50 day moving average in a Bearish Manner : CHRT-GB : May 23, 2016 -
02/12/16 03:10 PMCohort Plc : Undervalued relative to peers, but don’t ignore the other factors -
01/11/16 04:59 PMPositive safety of first cohort in Progenza stem cell trial for knee osteoarthritis - [at noodls] - Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced completion of a review of safety from the first cohort of 10 patients in the STEP trial. A review of the safety data ...
01/02/16 06:18 PMCohort Plc Earnings Analysis: H1, 2015 By the Numbers -
12/18/15 07:00 AMWould You Head Back Home If You Forgot Your Wallet? Your Keys? Your Apple Watch? -
12/16/15 03:32 AMCohort Plc breached its 50 day moving average in a Bearish Manner : December 16, 2015 -
12/14/15 10:08 AMCohort reports 40% jump in half year operating profit -
11/19/15 11:30 AMHelix BioPharma Corp. Initiates Enrollment for Fourteenth Cohort in Polish Phase I/II Clinical Study of Its L-DOS47 Lung Cancer Drug - [at noodls] - PRESS RELEASE NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRES OR DISSEMINATION IN THE UNITED STATES 3-305 Industrial Parkway South Aurora, Ontario, Canada, L4G 6X7 Phone: (905) 841-2300 Fax: (905) 841-2244 ...
10/12/15 07:03 PMCohort subsidiary wins GBP3m support services contract -
08/05/15 04:48 AMCohort clinches EUR19m deal for EID -
04/30/15 10:47 AMUltimi risultati relativi alla valvola Perceval, presentati in occasione del 95° congresso dell’American Association of Thoracic Surgery - [at noodls] - Milano, 30 aprile 2015 - Sorin Group, (Codice Reuters: SORN.MI), leader mondiale nel trattamento delle malattie cardiovascolari, ha annunciato la presentazione di dati che dimostrano i migliori esiti clinici ...
04/16/15 08:56 AMPROTALEX ANNOUNCES FINDINGS FROM FINAL COHORT OF U.S. PHASE 1b TRIAL OF PRTX-100 IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS - [at noodls] - FOR IMMEDIATE RELEASE LHA Contact: Anne Marie Fields [email protected] 212.838.3777 PROTALEX ANNOUNCES FINDINGS FROM FINAL COHORT OF U.S. PHASE 1b TRIAL OF PRTX- 100 IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS ...

Social

About Cohort PLC

Cohort PLC logoCohort plc is a holding company. The Company operates through its four subsidiaries: MASS Consultants Limited (MASS), Marlborough Communications Limited (MCL), Systems Consultants Services Limited (SCS) and SEA (Group) Limited (SEA). MASS is a specialist defense and technology business focused on electronic warfare, information systems and cyber security. MCL is engaged in the sourcing, design and integration of communications and surveillance technology, as well as support and training for the United Kingdom end users, including the Ministry of Defense (MOD) and other government agencies. SCS is an independent advisory business operating in the defense and security markets. SEA is an electronic systems and software company operating in the defense, transport and offshore energy markets.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: CHRT
  • CUSIP:
Key Metrics:
  • Previous Close: $4.77
  • 50 Day Moving Average: $334.08
  • 200 Day Moving Average: $352.62
  • P/E Ratio: 18.62
  • P/E Growth: 0.00
  • Market Cap: $141.05M
  • Current Year EPS Consensus Estimate: $25.57 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: